Literature DB >> 9512939

Metabolism of (-)-(S)-nicotine by guinea pig and rat brain: identification of cotinine.

P Jacob1, M Ulgen, J W Gorrod.   

Abstract

Since the brain is the major site of pharmacological activity of nicotine, it was of interest to investigate the metabolism of nicotine by this organ. We now report our findings using guinea pig and rat brain as the enzyme source. Whole brains were removed and washed with isotonic KCl, blotted dry and cut into small pieces. The tissue was weighed and homogenized in pH 7.4 Tris-KCl buffer, 2 ml/g tissue. Incubations were carried out using 0.5 ml of brain homogenate and 0.1-1 mumol of nicotine at 37 degrees C. The reactions were terminated by freezing at -80 degrees C. The samples were extracted and analyzed by capillary GC with nitrogen-phosphorus detection. Cotinine was detected as the major metabolite and its identity confirmed by GC-MS. Cotinine formation may contribute to the detoxication pathway of nicotine and may be important in controlling nicotine levels in the brain. Furthermore, the conversion of nicotine to cotinine involves the intermediacy of nicotine-delta [1'(5')]-iminium ion, which is an alkylating agent. This finding supports the concept that reactive intermediates may play a role in the pharmacology and toxicology of nicotine.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9512939     DOI: 10.1007/BF03190975

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  9 in total

1.  Microsomal cytochrome P450 in human brain regions.

Authors:  S Bhamre; H K Anandatheerthavarada; S K Shankar; V Ravindranath
Journal:  Biochem Pharmacol       Date:  1992-09-25       Impact factor: 5.858

2.  Determination of nicotine metabolites in rat brain after peripheral radiolabeled nicotine administration: detection of nornicotine.

Authors:  P A Crooks; M Li; L P Dwoskin
Journal:  Drug Metab Dispos       Date:  1995-10       Impact factor: 3.922

Review 3.  Xenobiotic metabolism in brain.

Authors:  V Ravindranath; S Bhamre; S V Bhagwat; H K Anandatheerthavarada; S K Shankar; P S Tirumalai
Journal:  Toxicol Lett       Date:  1995-12       Impact factor: 4.372

Review 4.  Xenobiotic metabolism in brain.

Authors:  V Ravindranath; M R Boyd
Journal:  Drug Metab Rev       Date:  1995       Impact factor: 4.518

5.  Enzymatic oxidation of nicotine to nicotine 1'(5') iminium ion. A newly discovered intermediate in the metabolism of nicotine.

Authors:  P J Murphy
Journal:  J Biol Chem       Date:  1973-04-25       Impact factor: 5.157

6.  Selected ion monitoring method for determination of nicotine, cotinine and deuterium-labeled analogs: absence of an isotope effect in the clearance of (S)-nicotine-3',3'-d2 in humans.

Authors:  P Jacob; L Yu; M Wilson; N L Benowitz
Journal:  Biol Mass Spectrom       Date:  1991-05

7.  Metabolic oxidation of nicotine to chemically reactive intermediates.

Authors:  T L Nguyen; L D Gruenke; N Castagnoli
Journal:  J Med Chem       Date:  1979-03       Impact factor: 7.446

8.  (S)- and (R)-[11C]nicotine and the metabolite (R/S)-[11C]cotinine. Preparation, metabolite studies and in vivo distribution in the human brain using PET.

Authors:  C Halldin; K Någren; C G Swahn; B Långström; H Nybäck
Journal:  Int J Rad Appl Instrum B       Date:  1992-11

Review 9.  The metabolism of alicyclic amines to reactive iminium ion intermediates.

Authors:  J W Gorrod; G Aislaitner
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Jul-Sep       Impact factor: 2.441

  9 in total
  6 in total

Review 1.  Drug-metabolizing cytochrome P450s in the brain.

Authors:  Sharon L Miksys; Rachel F Tyndale
Journal:  J Psychiatry Neurosci       Date:  2002-11       Impact factor: 6.186

2.  Phenobarbital increases monkey in vivo nicotine disposition and induces liver and brain CYP2B6 protein.

Authors:  Anna M Lee; Sharon Miksys; Rachel F Tyndale
Journal:  Br J Pharmacol       Date:  2006-06-05       Impact factor: 8.739

3.  Effect of Brain CYP2B Inhibition on Brain Nicotine Levels and Nicotine Self-Administration.

Authors:  Kristine L P Garcia; Kathy Coen; Sharon Miksys; Anh Dzung Lê; Rachel F Tyndale
Journal:  Neuropsychopharmacology       Date:  2015-02-05       Impact factor: 7.853

4.  Studies on the interactions of tobacco leaf and tobacco smoke constituents and monoamine oxidase.

Authors:  Kay Castagnoli; Stefanus J Steyn; Geraldine Magnin; Cornelis J Van Der Schyf; Izel Fourie; Ashraf Khalil; Neal Castagnoli
Journal:  Neurotox Res       Date:  2002-03       Impact factor: 3.911

5.  The involvement of mesolimbic dopamine system in cotinine self-administration in rats.

Authors:  Xiaoying Tan; Cynthia M Ingraham; William J McBride; Zheng-Ming Ding
Journal:  Behav Brain Res       Date:  2021-09-23       Impact factor: 3.332

Review 6.  Cotinine: Pharmacologically Active Metabolite of Nicotine and Neural Mechanisms for Its Actions.

Authors:  Xiaoying Tan; Kent Vrana; Zheng-Ming Ding
Journal:  Front Behav Neurosci       Date:  2021-10-21       Impact factor: 3.617

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.